Effects of a Pedometer-based Unsupervised Exercise Program Upon Lifestyle Physical Activity of Asthmatic Adults
NCT ID: NCT01984281
Last Updated: 2017-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2013-11-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Intervention to Increase Physical Activity in Patients With Asthma
NCT03705702
An Online Behavior Change Intervention to Promote Physical Activity in Adults With Asthma
NCT05241223
Behavioral Intervention to Increase Physical Activity in Patients with Asthma: Identifying Responders
NCT05159076
Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma
NCT05364632
Comparison Between Continuous Versus Interval Exercise Training in Asthmatic Patients
NCT02489383
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pedometer-based prescription
After baseline assessments, the control group will receive a educational session, regarding important aspects of asthma (symptoms, treatment, exacerbations, triggers, etc) plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes) and a pedometer-based physical activity prescription, consisting of targets to be achieved (in terms of steps per day).
Pedometer-based physical activity prescription
After baseline assessments, both groups will receive a educational session, regarding important aspects of asthma plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes). Only the experimental group will receive a pedometer-based physical activity prescription, consisting of targets (steps per day) to be achieved. The initial target will be determined based on the average of steps per day assessed during the baseline assessments plus 1000 steps. The targets will be biweekly. Both groups will be contact once a week (by phone) and will be asked to return for asthma control assessments once a month.
Control
After baseline assessments, the control group will receive a educational session, regarding important aspects of asthma (symptoms, treatment, exacerbations, triggers, etc) plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pedometer-based physical activity prescription
After baseline assessments, both groups will receive a educational session, regarding important aspects of asthma plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes). Only the experimental group will receive a pedometer-based physical activity prescription, consisting of targets (steps per day) to be achieved. The initial target will be determined based on the average of steps per day assessed during the baseline assessments plus 1000 steps. The targets will be biweekly. Both groups will be contact once a week (by phone) and will be asked to return for asthma control assessments once a month.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular drug therapy (inhaled corticosteroids or inhaled corticosteroids plus long-acting beta-agonists)
* Clinical stability during the run-in period (3 weeks)
Exclusion Criteria
* Disabling musculoskeletal disease
* Cardiopathy
* Other lung disease
* More than 10 pack-years of smoking
* Pregnancy
* Refusal to participate
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Juiz de Fora
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cristina Martins Coelho
MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno V Pinheiro, DSc
Role: STUDY_DIRECTOR
Federal University of Juiz de Fora
Cristina M Coelho, MSc
Role: PRINCIPAL_INVESTIGATOR
Federal University of Juiz de Fora
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of the Federal University of Juiz de Fora
Juiz de Fora, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13804413.3.1001.5133
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.